ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
INVO BioScience Inc

INVO BioScience Inc (INVO)

0,833
0,00
(0,00%)
Geschlossen 25 Januar 10:00PM
0,00
0,00
(0,00%)
Nach Börsenschluss: -

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
0,833
Gebot
0,827
Fragen
0,839
Volumen
-
0,00 Tagesbereich 0,00
0,6311 52-Wochen-Bereich 3,50
Marktkapitalisierung
Handelsende
0,833
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
-
Ausgegebene Aktien
3.906.072
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,40
Gewinn pro Aktie (EPS)
-2,06
Erlöse
3,02M
Nettogewinn
-8,04M

Über INVO BioScience Inc

INVO Bioscience Inc operates as a medical device company focused on creating simplified, lower cost treatments for patients diagnosed with infertility. INVO Bioscience Inc operates as a medical device company focused on creating simplified, lower cost treatments for patients diagnosed with infertility.

Sektor
Surgical,med Instr,apparatus
Branche
Surgical,med Instr,apparatus
Hauptsitz
Las Vegas, Nevada, USA
Gegründet
-
INVO BioScience Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker INVO. The last closing price for INVO BioScience was US$0,83. Over the last year, INVO BioScience shares have traded in a share price range of US$ 0,6311 to US$ 3,50.

INVO BioScience currently has 3.906.072 shares in issue. The market capitalisation of INVO BioScience is US$3,25 million. INVO BioScience has a price to earnings ratio (PE ratio) of -0.40.

INVO Neueste Nachrichten

NAYA Biosciences Announces Initiation of Phase 1/2a Clinical Trial for its GPC3-targeted NK Engager Bispecific Antibody in Patients with Hepatocellular Carcinoma

SARASOTA, Fla. and MIAMI, Oct. 24, 2024 (GLOBE NEWSWIRE) -- NAYA Biosciences (“NAYA”) (NASDAQ: NAYA), a life science portfolio company dedicated to bringing breakthrough treatments to patients...

INVO Bioscience Confirms Corporate Name Change and New Trading Symbol in Connection with Its Recent Merger with NAYA Biosciences

SARASOTA, Fla. and MIAMI, Oct. 21, 2024 (GLOBE NEWSWIRE) -- INVO Biosciences (Nasdaq: INVO), a company focused on expanding its portfolio of clinical and commercial-stage assets in fertility...

INVO Bioscience and NAYA Biosciences Close Merger, Combined Company to Operate as NAYA Biosciences (NASDAQ: NAYA)

SARASOTA, Fla. and MIAMI, Oct. 14, 2024 (GLOBE NEWSWIRE) -- INVO Bioscience (“INVO”) (NASDAQ: INVO) today announced it has closed its merger with NAYA Biosciences, a company dedicated to...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1000.8330.8330.83300CS
4000.8330.8330.83300CS
12000.8330.8330.83300CS
260.04555.777777777780.78751.420.63115763231.17281512CS
52-0.247-22.87037037041.083.50.631112792551.62806418CS
156-58.967-98.607023411459.8720.59238572.64433623CS
260-62.567-98.686119873863.42460.578987428.34141705CS

INVO - Frequently Asked Questions (FAQ)

What is the current INVO BioScience share price?
The current share price of INVO BioScience is US$ 0,833
How many INVO BioScience shares are in issue?
INVO BioScience has 3.906.072 shares in issue
What is the market cap of INVO BioScience?
The market capitalisation of INVO BioScience is USD 3,25M
What is the 1 year trading range for INVO BioScience share price?
INVO BioScience has traded in the range of US$ 0,6311 to US$ 3,50 during the past year
What is the PE ratio of INVO BioScience?
The price to earnings ratio of INVO BioScience is -0,4
What is the cash to sales ratio of INVO BioScience?
The cash to sales ratio of INVO BioScience is 1,07
What is the reporting currency for INVO BioScience?
INVO BioScience reports financial results in USD
What is the latest annual turnover for INVO BioScience?
The latest annual turnover of INVO BioScience is USD 3,02M
What is the latest annual profit for INVO BioScience?
The latest annual profit of INVO BioScience is USD -8,04M
What is the registered address of INVO BioScience?
The registered address for INVO BioScience is 187 E WARM SPRINGS ROAD, SUITE B, LAS VEGAS, NEVADA, 89119
What is the INVO BioScience website address?
The website address for INVO BioScience is www.invobioscience.com
Which industry sector does INVO BioScience operate in?
INVO BioScience operates in the SURGICAL,MED INSTR,APPARATUS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
NVNINVNI Group Ltd
US$ 4,38
(193,96%)
366,98M
EVAXEvaxion Biotech AS
US$ 5,99
(64,56%)
55,41M
ELABPMGC Holdings Inc
US$ 3,0901
(56,07%)
76,48M
PCLAPicoCELA Inc
US$ 4,60
(49,35%)
3,75M
GOEVCanoo Inc
US$ 0,475
(43,94%)
282,22M
GODNUGolden Star Acquisition Corporation
US$ 3,11
(-75,82%)
17,51k
GODNGolden Star Acquisition Corporation
US$ 2,93
(-65,67%)
902,76k
NXTTNext Technology Holding Inc
US$ 1,37
(-54,93%)
2,56M
SGLYSingularity Future Technology Ltd
US$ 1,625
(-38,45%)
917,77k
WHLRLWheeler Real Estate Investment Trust Inc
US$ 90,11
(-38,07%)
8
ACONAclarion Inc
US$ 0,0557
(28,94%)
811,91M
NVNINVNI Group Ltd
US$ 4,38
(193,96%)
366,98M
RIMEAlgorhythm Holdings Inc
US$ 0,0357
(4,69%)
284,97M
GOEVCanoo Inc
US$ 0,475
(43,94%)
282,22M
NVDANVIDIA Corporation
US$ 142,62
(-3,12%)
232,88M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock